Abstract: . . .  NSAIDs for the treatment of Osteoarthritis and Rheumatism? Letter 5, March 1995: Anti-Infection Guidelines for Community-aquired Infections. Letter 6, May 1995: Medical Management of Ischemic Heart Disease: The Optimal use of Nitrates. Letter 7, June 1995: Drugs of Choice in the Treatment of Hypertension , Part 1. Letter 8, July/August 1995: Drugs of Choice in the Treatment of Hypertension , Part 2. The Initiative is also committed to evaluate the effect of all educational interventions on patterns of prescription writing utilizing the Pharmacare database and other sources of data. If you have any questions about the Therapeutics Initiative, or if you are missing a Therapeutics . . .
. . .  the treatment of Osteoarthritis and Rheumatism? Letter 5, March 1995: Anti-Infection Guidelines for Community-aquired Infections. Letter 6, May 1995: Medical Management of Ischemic Heart Disease: The Optimal use of Nitrates. Letter 7, June 1995: Drugs of Choice in the Treatment of Hypertension , Part 1. Letter 8, July/August 1995: Drugs of Choice in the Treatment of Hypertension , Part 2. The Initiative is also committed to evaluate the effect of all educational interventions on patterns of prescription writing utilizing the Pharmacare database and other sources of data. If you have any questions about the Therapeutics Initiative, or if you are missing a Therapeutics Letter . . .
. . .  questions about the Therapeutics Initiative, or if you are missing a Therapeutics Letter please contact us at the numbers below. The Therapeutics Initiative must be credible to the physicians and pharmacists in the province. For this reason, the Initiative was established in the University and made independent from the government and any other vested interest groups.  . . .
. . .  of Osteoarthritis and Rheumatism? Letter 5, March 1995: Anti-Infection Guidelines for Community-aquired Infections. Letter 6, May 1995: Medical Management of Ischemic Heart Disease: The Optimal use of Nitrates. Letter 7, June 1995: Drugs of Choice in the Treatment of Hypertension , Part 1. Letter 8, July/August 1995: Drugs of Choice in the Treatment of Hypertension , Part 2. The Initiative is also committed to evaluate the effect of all educational interventions on patterns of prescription writing utilizing the Pharmacare database and other sources of data. If you have any questions about the Therapeutics Initiative, or if you are missing a Therapeutics Letter please contact . . .
--3000,4,375,2953,19425